Nomura Holdings
ECYT

Nomura Holdings’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Nomura Holdings’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-29,506
Closed -$140K – 2200
2015
Q3 		$140K Sell
29,506
-27,294
-48% -$143K ﹤0.01% 1477
2015
Q2 		$301K Buy
56,800
+37,097
+188% +$223K ﹤0.01% 1454
2015
Q1 		$124K Sell
19,703
-8,922
-31% -$51.5K ﹤0.01% 1577
2014
Q4 		$180K Sell
28,625
-123,284
-81% -$751K ﹤0.01% 2079
2014
Q3 		$935K Buy
151,909
+133,542
+727% +$912K ﹤0.01% 1472
2014
Q2 		$121K Buy
18,367
+7,050
+62% +$79.4K ﹤0.01% 2500
2014
Q1 		$267K Sell
11,317
-19,978
-64% -$290K ﹤0.01% 2163
2013
Q4 		$333K Buy
31,295
+875
+3% +$9.66K ﹤0.01% 1486
2013
Q3 		$406K Sell
30,420
-9,751
-24% -$154K ﹤0.01% 1509
2013
Q2 		$528K Buy
+40,171
New +$542K ﹤0.01% 1283

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nomura Holdings's ECYT Position: Q4 2015 in Review

Nomura Holdings sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2015, closing a stake of 29,506 shares — an estimated $140K sold.

Nomura Holdings first reported a position in ECYT in Q2 2013 and held it in 10 quarters. The position peaked at $935K in Q3 2014. 102 funds tracked by Wall St. Rank hold ECYT as of Q4 2015.

  • Nomura Holdings reported no remaining Endocyte, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Nomura Holdings sold 29,506 Endocyte, Inc. Common Stock shares in Q4 2015, an estimated $140K.
  • Nomura Holdings first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 10 quarters.
  • Nomura Holdings's Endocyte, Inc. Common Stock position peaked at $935K in Q3 2014.
  • 102 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2015.

Based on Nomura Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.